NANJING, JIANGSU, CHINA -- (MARKET WIRE) -- 01/06/2006 -- China Biopharmaceuticals Holdings, Inc. (OTC BB: CHBP) (“CHINA BIOPHARMACEUTICALS” or the “Company”), a China-based advanced and vertically integrated biopharmaceutical company focused on developing and commercializing innovative drugs, today announced that on December 31, 2005 it entered into an Agreement with the shareholders of Chengdu Tianyin Pharmaceutical Limited Company (“Tianyin”) to immediately assume operation control of Tianyin in all aspects of its business operations and to acquire a 51% ownership interest in Tianyin.